News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
Press Releases
Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024
September 24, 2024
·
3 min read
Press Releases
Cardiol Therapeutics Achieves Target Patient Enrollment in its Phase II ARCHER Trial Investigating CardiolRx(TM) for Acute Myocarditis
September 24, 2024
·
8 min read
Press Releases
American Aires Enters into Capital Markets Advisory Agreement with Tech-Focused Sophic Capital Inc.
September 24, 2024
·
7 min read
Press Releases
MustGrow Provides 2024 Pipeline Update
September 24, 2024
·
12 min read
Press Releases
Tim Hawkins Joins Rephine as CEO to Spearhead Global Leadership
September 23, 2024
·
3 min read
Press Releases
Therma Bright Investment Portfolio Company InStatin Secures Mountain West Research Discovery Study Agreement
September 23, 2024
·
3 min read
Press Releases
BioHarvest Sciences Reports Director’s Ongoing Key Role Following Resignation from Board
September 20, 2024
·
2 min read
Press Releases
NervGen Pharma to Present at the Unite 2 Fight Paralysis 19th Annual Science & Advocacy Symposium Focused on Spinal Cord Injury
September 20, 2024
·
6 min read
Press Releases
Medexus Holds Annual Meeting of Shareholders and Announces Election of Directors
September 20, 2024
·
3 min read
Press Releases
ME Therapeutics Announces the Start of Testing of First mRNA Formulations from NanoVation Therapeutics Collaboration
September 18, 2024
·
3 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us